Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
75,239 questions in 5,342 reviews
current versionsNo studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings table ‐ Laparoscopic vs hand‐assisted Ureteric complications ‐ not reported · live donor nephrectomy (secondary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Laparoscopic vs hand‐assisted Kidney function at one year ‐ not reported · live donor nephrectomy (secondary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Laparoscopic vs hand‐assisted One‐year graft loss · live donor nephrectomy (secondary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | RR 1.31 [0.51, 3.37] | 2 studies · 230 participants | Low |
Summary of findings table ‐ Open vs laparoscopic Blood loss · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | no estimate extracted | 6 studies · 775 participants | Moderate |
Summary of findings table ‐ Open vs laparoscopic Perioperative complications: pre 2010 · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | RR 0.66 [0.39, 1.11] | 4 studies · 464 participants | Very low |
Summary of findings table ‐ Open vs laparoscopic Perioperative complications: post 2010 · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | RR 2.19 [1.53, 3.13] | 2 studies · 303 participants | Very low |
Summary of findings table ‐ Open vs laparoscopic Perioperative complications: total · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | RR 1.02 [0.55, 1.89] | 6 studies · 767 participants | Very low |
Summary of findings table ‐ Open vs laparoscopic Reoperations · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | RR 0.57 [0.09, 3.64] | 6 studies · 596 participants | Very low |
Summary of findings table ‐ Open vs laparoscopic Warm ischaemia time · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | no estimate extracted | 7 studies · 815 participants | Moderate |
Summary of findings table ‐ Open vs laparoscopic Hospital stay · live donor nephrectomy (primary outcomes) Robotic versus laparoscopic versus open nephrectomy for live kidney donors (2024) · Cochrane | no estimate extracted | 6 studies · 775 participants | Moderate |
Dextranomer beads (autolytic) vs Eusol gauze Time to a clean wound bed ( · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 20 participants | Very low |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Proportion of wounds completely healed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Time to complete healing (days) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
Dextranomer paste (autolytic) vs 0.1% chloramine‐soaked dressings Time to a clean wound bed ( · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 28 participants | Very low |
Dextranomer paste (autolytic) vs 0.1% chloramine‐soaked dressings Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 0.1% chloramine‐soaked dressings Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 0.1% chloramine‐soaked dressings Proportion of wounds completely healed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 0.1% chloramine‐soaked dressings Time to complete healing (days) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 28 participants | Very low |
Dextranomer paste (autolytic) vs 0.1% chloramine‐soaked dressings Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 28 participants | Low |
Dextranomer beads (autolytic) vs silicone foam elastomer (autolytic) Time to a clean wound bed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs Eusol gauze Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs silicone foam elastomer (autolytic) Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs silicone foam elastomer (autolytic) Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs silicone foam elastomer (autolytic) Proportion of wounds completely healed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs silicone foam elastomer (autolytic) Time to complete healing (days) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 50 participants | Very low |
Dextranomer beads (autolytic) vs silicone foam elastomer (autolytic) Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Streptokinase/streptodornase (enzymatic) vs saline‐soaked dressing Time to a clean wound bed ( · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 21 participants | Low |
Streptokinase/streptodornase (enzymatic) vs saline‐soaked dressing Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Streptokinase/streptodornase (enzymatic) vs saline‐soaked dressing Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Streptokinase/streptodornase (enzymatic) vs saline‐soaked dressing Proportion of wounds completely healed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Streptokinase/streptodornase (enzymatic) vs saline‐soaked dressing Time to complete healing (days) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs Eusol gauze Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Streptokinase/streptodornase (enzymatic) vs saline‐soaked dressing Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 21 participants | Very low |
Surgical debridement via an endoscopic method vs conventional 'open' surgical debridement Time to a clean wound bed (minutes) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 106 participants | Very low |
Surgical debridement via an endoscopic method vs conventional 'open' surgical debridement Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical debridement via an endoscopic method vs conventional 'open' surgical debridement Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical debridement via an endoscopic method vs conventional 'open' surgical debridement Proportion of wounds completely healed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Surgical debridement via an endoscopic method vs conventional 'open' surgical debridement Time to complete healing ( · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 106 participants | Low |
Surgical debridement via an endoscopic method vs conventional 'open' surgical debridement Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs Eusol gauze Proportion of wounds completely healed · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs Eusol gauze Time to complete healing (days) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs Eusol gauze Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Time to a clean wound bed ( · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 40 participants | Very low |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Angiotensin‐converting‐enzyme inhibitors vs placebo or no treatment All‐cause death Median · people with diabetes and kidney disease Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of… (2024) · Cochrane | RR 0.91 [0.73, 1.15] | 24 studies · 7413 participants | Low |
Angiotensin receptor blockers vs placebo or no treatment Doubling of SCr Median · people with diabetes and kidney disease Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of… (2024) · Cochrane | RR 0.84 [0.72, 0.97] | 4 studies · 3280 participants | Low |
Angiotensin receptor blockers vs placebo or no treatment Fatal or nonfatal stroke Median · people with diabetes and kidney disease Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of… (2024) · Cochrane | RR 0.76 [0.32, 1.77] | 2 studies · 619 participants | Low |
Angiotensin receptor blockers vs placebo or no treatment Fatal or nonfatal myocardial infarction Median · people with diabetes and kidney disease Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of… (2024) · Cochrane | RR 0.43 [0.11, 1.65] | 2 studies · 619 participants | Low |